BioAtla, Inc. (NASDAQ:BCAB) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event. BioAtla, Inc.'s stock currently trades…
BioAtla, Inc. (NASDAQ:BCAB) filed a Form 8-K with the Securities and Exchange Commission on January 30, 2026, disclosing a material event.
BioAtla, Inc.'s stock currently trades at $0.27 with a market capitalization of $46.1M. The Healthcare company's stock moved following the disclosure.
Current market data
NASDAQ · BCAB
$1.74
Up: +$0.42 · +31.44%
Live quote updated
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
earnings ·
